{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:09:27Z","timestamp":1768003767044,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH","award":["R01CA266702"],"award-info":[{"award-number":["R01CA266702"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04737-3","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T04:17:50Z","timestamp":1733977070000},"page":"3249-3261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intravesical BCG therapy: implications for radiologists in abdominal imaging follow-up"],"prefix":"10.1007","volume":"50","author":[{"given":"Manisha","family":"Naganatanahalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohrab","family":"Afshari Mirak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijayanadh","family":"Ojili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil H.","family":"Ramaiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sree Harsha","family":"Tirumani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"key":"4737_CR1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten, L. M. C. et al. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat. Rev. Clin. Oncol. 20, 287\u2013304 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"4737_CR2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.juro.2013.08.022","volume":"191","author":"JP Sfakianos","year":"2014","unstructured":"Sfakianos, J. P., Kim, P. H., Hakimi, A. A. & Herr, H. W. The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Gu\u00e9rin. J. Urol. 191, 341\u2013345 (2014).","journal-title":"J. Urol."},{"key":"4737_CR3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","volume":"15","author":"C Pettenati","year":"2018","unstructured":"Pettenati, C. & Ingersoll, M. A. Mechanisms of BCG immunotherapy and its outlook for bladder cancer. Nat. Rev. Urol. 15, 615\u2013625 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"4737_CR4","doi-asserted-by":"crossref","unstructured":"Lopez-Beltran, A., Cookson, M. S., Guercio, B. J. & Cheng, L. Advances in diagnosis and treatment of bladder cancer. BMJ 384, e076743 (2024).","DOI":"10.1136\/bmj-2023-076743"},{"key":"4737_CR5","unstructured":"Complications of Intravesical BCG Immunotherapy for Bladder Cancer| RadioGraphics. https:\/\/pubs.rsna.org\/doi\/10.1148\/rg.2019180014."},{"key":"4737_CR6","doi-asserted-by":"crossref","unstructured":"Lamm, D. L. et al. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J. Urol. 147, 596\u2013600 (1992).","DOI":"10.1016\/S0022-5347(17)37316-0"},{"key":"4737_CR7","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.2214\/AJR.08.1962","volume":"192","author":"W Ma","year":"2009","unstructured":"Ma, W., Kang, S. K., Hricak, H., Gerst, S. R. & Zhang, J. Imaging appearance of granulomatous disease after intravesical Bacille Calmette-Guerin (BCG) treatment of bladder carcinoma. AJR Am. J. Roentgenol. 192, 1494\u20131500 (2009).","journal-title":"AJR Am. J. Roentgenol."},{"key":"4737_CR8","first-page":"100149","volume":"19","author":"R Waked","year":"2020","unstructured":"Waked, R., Choucair, J., Chehata, N., Haddad, E. & Saliba, G. Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) treatment\u2019s severe complications: A single institution review of incidence, presentation and treatment outcome. J. Clin. Tuberc. Mycobact. Dis. 19, 100149 (2020).","journal-title":"J. Clin. Tuberc. Mycobact. Dis."},{"key":"4737_CR9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ajur.2022.12.006","volume":"10","author":"C Ma","year":"2023","unstructured":"Ma, C. et al. The natural course of bacillus Calmette-Gu\u00e9rin induced bladder lesions: A long-term follow-up study and systematic review. Asian J. Urol. 10, 356\u2013363 (2023).","journal-title":"Asian J. Urol."},{"issue":"Suppl 2","key":"4737_CR10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000474920","volume":"21","author":"A Steg","year":"1992","unstructured":"Steg, A., Adjiman, S. & Debr\u00e9, B. BCG therapy in superficial bladder tumours\u2013complications and precautions. Eur. Urol. 21 Suppl 2, 35\u201340 (1992).","journal-title":"Eur. Urol."},{"key":"4737_CR11","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","volume":"147","author":"DL Lamm","year":"1992","unstructured":"Lamm, D. L. et al. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J. Urol. 147, 596\u2013600 (1992).","journal-title":"J. Urol."},{"key":"4737_CR12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.juro.2014.02.2573","volume":"192","author":"AM Kamat","year":"2014","unstructured":"Kamat, A. M. et al. Defining and Treating the Spectrum of Intermediate-Risk NMIBC. J. Urol. 192, 305\u2013315 (2014).","journal-title":"J. Urol."},{"key":"4737_CR13","unstructured":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)\u2013\u20092019 Update - ClinicalKey. https:\/\/www.clinicalkey.com\/#!\/content\/playContent\/1-s2.0-S0302283819306608."},{"key":"4737_CR14","doi-asserted-by":"crossref","first-page":"151558","DOI":"10.1016\/j.ijmm.2022.151558","volume":"312","author":"AA Malik","year":"2022","unstructured":"Malik, A. A., Sheikh, J. A., Ehtesham, N. Z., Hira, S. & Hasnain, S. E. Can Mycobacterium tuberculosis infection lead to cancer? Call for a paradigm shift in understanding TB and cancer. Int. J. Med. Microbiol. IJMM 312, 151558 (2022).","journal-title":"Int. J. Med. Microbiol. IJMM"},{"key":"4737_CR15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales, A., Eidinger, D. & Bruce, A. W. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J. Urol. 116, 180\u2013183 (1976).","journal-title":"J. Urol."},{"key":"4737_CR16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1148\/radiol.2019182506","volume":"291","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion. Radiology 291, 668\u2013674 (2019).","journal-title":"Radiology"},{"key":"4737_CR17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2007-1001917","volume":"20","author":"DH Schamhart","year":"1994","unstructured":"Schamhart, D. H., De Boer, E. C., Vleeming, R. & Kurth, K. H. Theoretical and experimental evidence on the use of glycosaminoglycans in BCG-mediated immunotherapy of superficial bladder cancer. Semin. Thromb. Hemost. 20, 301\u2013309 (1994).","journal-title":"Semin. Thromb. Hemost."},{"key":"4737_CR18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-5347(17)42445-1","volume":"139","author":"TL Ratliff","year":"1988","unstructured":"Ratliff, T. L., Kavoussi, L. R. & Catalona, W. J. Role of fibronectin in intravesical BCG therapy for superficial bladder cancer. J. Urol. 139, 410\u2013414 (1988).","journal-title":"J. Urol."},{"key":"4737_CR19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/bjc.1998.545","volume":"78","author":"O Jansson","year":"1998","unstructured":"Jansson, O. et al. The role of nitric oxide in bacillus Calmette-Gu\u00e9rin mediated anti-tumour effects in human bladder cancer. Br. J. Cancer 78, 588\u2013592 (1998).","journal-title":"Br. J. Cancer"},{"key":"4737_CR20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","volume":"91","author":"RFM Bevers","year":"2004","unstructured":"Bevers, R. F. M., Kurth, K.-H. & Schamhart, D. H. J. Role of urothelial cells in BCG immunotherapy for superficial bladder cancer. Br. J. Cancer 91, 607 (2004).","journal-title":"Br. J. Cancer"},{"key":"4737_CR21","doi-asserted-by":"publisher","unstructured":"Bacillus Calmette\u2013Gu\u00e9rin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections - Larsen\u2013\u20092020 - APMIS - Wiley Online Library. https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/apm.13011.","DOI":"10.1111\/apm.13011"},{"key":"4737_CR22","doi-asserted-by":"crossref","unstructured":"Borges, V. M., Marinho, F. V., Caldeira, C. V. A., de Queiroz, N. M. G. P. & Oliveira, S. C. Bacillus Calmette-Gu\u00e9rin immunotherapy induces an efficient antitumor response to control murine melanoma depending on MyD88 signaling. Front. Immunol. 15, (2024).","DOI":"10.3389\/fimmu.2024.1380069"},{"key":"4737_CR23","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.3390\/cancers15071937","volume":"15","author":"F Del Giudice","year":"2023","unstructured":"Del Giudice, F. et al. Efficacy of Different Bacillus of Calmette-Gu\u00e9rin (BCG) Strains on Recurrence Rates among Intermediate\/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis. Cancers 15, 1937 (2023).","journal-title":"Cancers"},{"key":"4737_CR24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.juro.2017.01.086","volume":"198","author":"BE Boehm","year":"2017","unstructured":"Boehm, B. E. et al. Efficacy of bacillus Calmette-Gu\u00e9rin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis. J. Urol. 198, 503\u2013510 (2017).","journal-title":"J. Urol."},{"key":"4737_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.06.049","author":"SS Chang","year":"2016","unstructured":"Chang, S. S. et al. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA\/SUO Guideline. J. Urol. (2016) doi:https:\/\/doi.org\/10.1016\/j.juro.2016.06.049.","journal-title":"J. Urol."},{"key":"4737_CR26","doi-asserted-by":"crossref","unstructured":"To, U., Kim, J. & Chia, D. Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment. Case Rep. Med. 2014, 362845 (2014).","DOI":"10.1155\/2014\/362845"},{"key":"4737_CR27","doi-asserted-by":"crossref","first-page":"S417","DOI":"10.1016\/j.jacr.2019.05.026","volume":"16","author":"BC Allen","year":"2019","unstructured":"Allen, B. C. et al. ACR Appropriateness Criteria\u00ae Post-Treatment Surveillance of Bladder Cancer. J. Am. Coll. Radiol. 16, S417\u2013S427 (2019).","journal-title":"J. Am. Coll. Radiol."},{"key":"4737_CR28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2009.04.038","volume":"56","author":"P-U Malmstr\u00f6m","year":"2009","unstructured":"Malmstr\u00f6m, P.-U. et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Gu\u00e9rin for non-muscle-invasive bladder cancer. Eur. Urol. 56, 247\u2013256 (2009).","journal-title":"Eur. Urol."},{"key":"4737_CR29","doi-asserted-by":"crossref","unstructured":"Shelley, M. D. et al. A systematic review of intravesical bacillus Calmette-Gu\u00e9rin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer. BJU Int. 88, 209\u2013216 (2001).","DOI":"10.1046\/j.1464-410x.2001.02306.x"},{"key":"4737_CR30","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.urology.2005.12.014","volume":"67","author":"RF Han","year":"2006","unstructured":"Han, R. F. & Pan, J. G. Can intravesical bacillus Calmette-Gu\u00e9rin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Urology 67, 1216\u20131223 (2006).","journal-title":"Urology"},{"key":"4737_CR31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1464-410X.2003.04655.x","volume":"93","author":"MD Shelley","year":"2004","unstructured":"Shelley, M. D. et al. Intravesical bacillus Calmette-Gu\u00e9rin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials. BJU Int. 93, 485\u2013490 (2004).","journal-title":"BJU Int."},{"key":"4737_CR32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-5347(05)64043-8","volume":"169","author":"A B\u00f6hle","year":"2003","unstructured":"B\u00f6hle, A., Jocham, D. & Bock, P. R. Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J. Urol. 169, 90\u201395 (2003).","journal-title":"J. Urol."},{"key":"4737_CR33","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.urology.2003.11.049","volume":"63","author":"A B\u00f6hle","year":"2004","unstructured":"B\u00f6hle, A. & Bock, P. R. Intravesical bacille Calmette-Gu\u00e9rin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology 63, 682\u2013686; discussion 686\u2013687 (2004).","journal-title":"Urology"},{"key":"4737_CR34","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","volume":"168","author":"RJ Sylvester","year":"2002","unstructured":"Sylvester, R. J., van der MEIJDEN, A. P. M. & Lamm, D. L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J. Urol. 168, 1964\u20131970 (2002).","journal-title":"J. Urol."},{"key":"4737_CR35","doi-asserted-by":"crossref","unstructured":"Sylvester, R. J. et al. Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Gu\u00e9rin, and bacillus Calmette-Gu\u00e9rin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder. Eur. Urol. 57, 766\u2013773 (2010).","DOI":"10.1016\/j.eururo.2009.12.024"},{"key":"4737_CR36","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.3390\/jcm13144112","volume":"13","author":"R Passarelli","year":"2024","unstructured":"Passarelli, R. & Packiam, V. T. Contemporary Treatment of NMIBC\u2014Is It Time to Move on from BCG? J. Clin. Med. 13, 4112 (2024).","journal-title":"J. Clin. Med."},{"key":"4737_CR37","unstructured":"Bladder Cancer: Non-Muscle Invasive Guideline - American Urological Association. https:\/\/www.auanet.org\/guidelines-and-quality\/guidelines\/bladder-cancer-non-muscle-invasive-guideline."},{"key":"4737_CR38","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.1038\/s41598-020-66952-4","volume":"10","author":"TJ Kim","year":"2020","unstructured":"Kim, T. J. et al. Analysis of risk factors for post-bacillus Calmette\u2013Guerin-induced prostatitis in patients with non-muscle invasive bladder cancer. Sci. Rep. 10, 9763 (2020).","journal-title":"Sci. Rep."},{"key":"4737_CR39","unstructured":"Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer - ClinicalKey. https:\/\/www.clinicalkey.com\/#!\/content\/playContent\/1-s2.0-S1078143912003432."},{"key":"4737_CR40","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s00261-017-1195-3","volume":"42","author":"J Choe","year":"2017","unstructured":"Choe, J. et al. Updates for the radiologist in non-muscle-invasive, muscle-invasive, and metastatic bladder cancer. Abdom. Radiol. 42, 2710\u20132724 (2017).","journal-title":"Abdom. Radiol."},{"key":"4737_CR41","doi-asserted-by":"crossref","first-page":"S417","DOI":"10.1016\/j.jacr.2019.05.026","volume":"16","author":"Expert Panel on Urologic Imaging","year":"2019","unstructured":"Expert Panel on Urologic Imaging et al. ACR Appropriateness Criteria\u00ae Post-Treatment Surveillance of Bladder Cancer. J. Am. Coll. Radiol. JACR 16, S417\u2013S427 (2019).","journal-title":"J. Am. Coll. Radiol. JACR"},{"key":"4737_CR42","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1007\/s00261-017-1449-0","volume":"43","author":"CB van der Pol","year":"2018","unstructured":"van der Pol, C. B. et al. Bladder cancer local staging: multiparametric MRI performance following transurethral resection. Abdom. Radiol. 43, 2412\u20132423 (2018).","journal-title":"Abdom. Radiol."},{"key":"4737_CR43","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2214\/AJR.18.20718","volume":"212","author":"CS Lim","year":"2019","unstructured":"Lim, C. S. et al. Use of Quantitative T2-Weighted and Apparent Diffusion Coefficient Texture Features of Bladder Cancer and Extravesical Fat for Local Tumor Staging After Transurethral Resection. AJR Am. J. Roentgenol. 212, 1060\u20131069 (2019).","journal-title":"AJR Am. J. Roentgenol."},{"key":"4737_CR44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.18683\/germs.2023.1395","volume":"13","author":"D Marouli","year":"2023","unstructured":"Marouli, D. et al. Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection presenting as severe respiratory failure and septic shock. Germs 13, 277\u2013281 (2023).","journal-title":"Germs"},{"key":"4737_CR45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3348\/kjr.2015.16.2.342","volume":"16","author":"H Kawada","year":"2015","unstructured":"Kawada, H. et al. Multiphase Contrast-Enhanced Magnetic Resonance Imaging Features of Bacillus Calmette-Gu\u00e9rin-Induced Granulomatous Prostatitis in Five Patients. Korean J. Radiol. 16, 342\u2013348 (2015).","journal-title":"Korean J. Radiol."},{"key":"4737_CR46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.urolonc.2007.04.005","volume":"26","author":"JG Heiner","year":"2008","unstructured":"Heiner, J. G. & Terris, M. K. Effect of advanced age on the development of complications from intravesical bacillus Calmette-Gu\u00e9rin therapy. Urol. Oncol. 26, 137\u2013140 (2008).","journal-title":"Urol. Oncol."},{"key":"4737_CR47","doi-asserted-by":"crossref","unstructured":"Bourlotos, G., Baigent, W., Hong, M., Plagakis, S. & Grundy, L. BCG induced lower urinary tract symptoms during treatment for NMIBC\u2014Mechanisms and management strategies. Front. Neurosci. 17, (2024).","DOI":"10.3389\/fnins.2023.1327053"},{"key":"4737_CR48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.eururo.2013.07.021","volume":"65","author":"M Brausi","year":"2014","unstructured":"Brausi, M. et al. Side effects of Bacillus Calmette-Gu\u00e9rin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG. Eur. Urol. 65, 69\u201376 (2014).","journal-title":"Eur. Urol."},{"key":"4737_CR49","doi-asserted-by":"crossref","unstructured":"Liu, Y., Lu, J., Huang, Y. & Ma, L. Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Gu\u00e9rin for Bladder Cancer. J. Oncol. 2019, 6230409 (2019).","DOI":"10.1155\/2019\/6230409"},{"key":"4737_CR50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1148\/rg.2019180014","volume":"39","author":"DB Green","year":"2019","unstructured":"Green, D. B. et al. Complications of Intravesical BCG Immunotherapy for Bladder Cancer. RadioGraphics 39, 80\u201394 (2019).","journal-title":"RadioGraphics"},{"key":"4737_CR51","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s10147-017-1096-z","volume":"22","author":"M Matsushima","year":"2017","unstructured":"Matsushima, M. et al. Natural course of asymptomatic abnormal prostate findings incidentally detected by CT after intravesical BCG therapy. Int. J. Clin. Oncol. 22, 554\u2013562 (2017).","journal-title":"Int. J. Clin. Oncol."},{"key":"4737_CR52","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0022-5347(05)67025-5","volume":"164","author":"D Leibovici","year":"2000","unstructured":"Leibovici, D. et al. Elevated prostate specific antigen serum levels after intravesical instillation of bacillus Calmette-Guerin. J. Urol. 164, 1546\u20131549 (2000).","journal-title":"J. Urol."},{"key":"4737_CR53","doi-asserted-by":"crossref","unstructured":"Harada, H. et al. Epididymo-orchitis caused by intravesically instillated bacillus Calmette-Gu\u00e9rin: genetically proven using a multiplex polymerase chain reaction method. Int. J. Urol. 13, 183\u2013185 (2006).","DOI":"10.1111\/j.1442-2042.2006.01257.x"},{"key":"4737_CR54","first-page":"1361","volume":"13","author":"H Yusuke","year":"2006","unstructured":"Yusuke, H., Yoshinori, H., Kenichi, M. & Akio, H. Granulomatous balanoposthitis after intravesical Bacillus-Calmette-Guerin instillation therapy. Int. J. Urol. Off. J. Jpn. Urol. Assoc. 13, 1361\u20131363 (2006).","journal-title":"Int. J. Urol. Off. J. Jpn. Urol. Assoc."},{"key":"4737_CR55","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijmyco.2013.11.002","volume":"3","author":"BJ Holmes","year":"2014","unstructured":"Holmes, B. J. et al. Mycotic aortic aneurysm due to intravesical BCG immunotherapy: Clinical manifestations and diagnostic challenges. Int. J. Mycobacteriology 3, 60\u201365 (2014).","journal-title":"Int. J. Mycobacteriology"},{"key":"4737_CR56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejvsvf.2023.02.003","volume":"58","author":"J Haddad","year":"2023","unstructured":"Haddad, J., Chalret du Rieu, H., Ducasse, E., Berard, X. & Caradu, C. BCG Aortitis, a Rare Complication of BCG Therapy. EJVES Vasc. Forum 58, 23\u201327 (2023).","journal-title":"EJVES Vasc. Forum"},{"key":"4737_CR57","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.athoracsur.2014.07.083","volume":"99","author":"KP Seastedt","year":"2015","unstructured":"Seastedt, K. P. et al. Mycotic Thoracic Aortic Aneurysm After Intravesical Bacillus Calmette-Gu\u00e9rin Treatment. Ann. Thorac. Surg. 99, 2210\u20132212 (2015).","journal-title":"Ann. Thorac. Surg."},{"key":"4737_CR58","doi-asserted-by":"crossref","unstructured":"Costiniuk, C. T. et al. Mycobacterium bovis abdominal aortic and femoral artery aneurysms following intravesical bacillus Calmette-Gu\u00e9rin therapy for bladder cancer. Cardiovasc. Pathol. 19, e29\u201332 (2010).","DOI":"10.1016\/j.carpath.2008.09.003"},{"key":"4737_CR59","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000074100","volume":"71","author":"JA Witjes","year":"2003","unstructured":"Witjes, J. A., Vriesema, J. L. J., Brinkman, K., Bootsma, G. & Barentsz, J. O. Mycotic aneurysm of the popliteal artery as a complication of intravesical BCG therapy for superficial bladder cancer. Case report and literature review. Urol. Int. 71, 430\u2013432 (2003).","journal-title":"Urol. Int."},{"key":"4737_CR60","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jvs.2009.06.004","volume":"50","author":"R Coscas","year":"2009","unstructured":"Coscas, R., Arlet, J.-B., Belhomme, D., Fabiani, J.-N. & Pouchot, J. Multiple mycotic aneurysms due to Mycobacterium bovis after intravesical bacillus Calmette-Gu\u00e9rin therapy. J. Vasc. Surg. 50, 1185\u20131190 (2009).","journal-title":"J. Vasc. Surg."}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04737-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04737-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04737-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T18:03:36Z","timestamp":1750442616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04737-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["4737"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04737-3","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}